Reduced dose versus standard melphalan conditioning for autologous stem cell transplantation in multiple myeloma: a single-center retrospective study
Abstract This retrospective, single‑center study evaluated the efficacy and safety of a reduced‑dose melphalan conditioning regimen (140–180 mg/m2) for autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM) ineligible for the standard dose (200 mg/m2). Clinical outcomes w...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer
2026-03-01
|
| Seri Bilgileri: | Annals of Hematology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s00277-026-06909-1 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|